Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for BIMI International Medical Inc. (BIMI : NSDQ)

• Company Description    BIMI International Medical Inc. is a healthcare product and services provider as well as operates private hospitals principally in China. BIMI International Medical Inc., formerly known as BOQI International Medical Inc., is based in NEW YORK. Number of Employees: 524

• Price / Volume Information    Yesterday's Closing Price: $0.63 Daily Weekly Monthly 20 Day Moving Average: 2,160,143 shares Shares Outstanding: 10.36 (millions) Market Capitalization: $6.47 (millions) Beta: 0.19 52 Week High: $7.78 52 Week Low: $0.48 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -36.48% -32.71% 12 Week -44.69% -39.57% Year To Date -75.49% -70.36%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9TH FLOOR BUILDING 2 CHONGQING CORPORATION AVENUE YUZHONG DISTRICT - CHONGQING P.R.,F4 404100 CHN ph: 86-023-6310-7239 fax: 86-24-8563-1159 ir@changqingconsulting.com http://www.usbimi.com

• General Corporate Information    Officers Tiewei Song - Chief Executive Officer and President Xiaoping Wang - Chief Operating Officer Baiqun Zhong - Chief Financial Officer Ju Li - Director Jianxi Wang - Director Peer Information BIMI International Medical Inc. (CHCR) BIMI International Medical Inc. (ESRX) BIMI International Medical Inc. (MYDP) BIMI International Medical Inc. (GBCS) BIMI International Medical Inc. (LAXAF) BIMI International Medical Inc. (IPCM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 05552Q202 SIC: 5122 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/15/22 Share - Related Items Shares Outstanding: 10.36 Most Recent Split Date: 2.00 (0.20:1) Beta: 0.19 Market Capitalization: $6.47 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/15/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.48 Price/Cash Flow: - Price / Sales: 0.22 EPS Growth vs. Year Ago Period: 73.00% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 131.55% vs. Previous Quarter: 167.31% ROE 03/31/22 - -152.46 12/31/21 - -138.12 09/30/21 - -39.37 ROA 03/31/22 - -67.87 12/31/21 - -65.47 09/30/21 - -20.15 Current Ratio 03/31/22 - 1.07 12/31/21 - 0.96 09/30/21 - 1.09 Quick Ratio 03/31/22 - - 12/31/21 - 0.84 09/30/21 - 1.00 Operating Margin 03/31/22 - -114.80 12/31/21 - -129.08 09/30/21 - -34.19 Net Margin 03/31/22 - -114.90 12/31/21 - -129.19 09/30/21 - -25.47 Pre-Tax Margin 03/31/22 - -114.75 12/31/21 - -128.88 09/30/21 - -32.99 Book Value 03/31/22 - 1.29 12/31/21 - 6.67 09/30/21 - 5.36 Inventory Turnover 03/31/22 - 8.13 12/31/21 - 6.69 09/30/21 - 8.59 Debt-to-Equity 03/31/22 - 0.04 12/31/21 - 0.05 09/30/21 - 0.02 Debt-to-Capital 03/31/22 - 3.80 12/31/21 - 4.53 09/30/21 - 2.23

Powered by Zacks Investment Research ©